Novaerus Meets Irish Prime Minister

The meeting took place on a trade mission to Frankfurt.

Seattle, WA – April 18, 2017 – Earlier this month, Novaerus and German partner Kaneka had the privilege of meeting with An Taoiseach (Irish Prime Minister) Enda Kenny. The meeting took place in Frankfurt during a trade mission.

Novaerus and Kaneka had the opportunity to discuss the importance of airborne infection control with the Taoiseach. They raised the pertinence of preventing hospital-acquired infections and the growing concern over indoor air quality. The reception was followed by a lunch at Frankfurter Hos.

The Taoiseach later gave a speech where he emphasized the importance of working to develop the relationships between Irish businesses and European partners.

About Novaerus

Novaerus provides a service that reduces airborne contaminants and educates its customers on the importance of healthy air. The patented, cost-effective air purification solutions remove harmful viruses, bacteria, mould, particulates, VOCs and odour.

To learn more about Novaerus and its air-purifying full-service solutions, visit www.novaerus.com.

 

Novaerus Signs New Partnership with French Company Azelies

Novaerus Signs New Partnership with French Company Azelies

Seattle, WA – March 16, 2017 – Novaerus celebrated St. Patrick’s Day a day early with a contract signing ceremony at the Irish Embassy in Paris. The contract secured a partnership with Azelies, a French company dedicated to revolutionizing access to medical equipment.

The event was hosted in an 18th-century mansion located just off Champs Elysee. It welcomed over 700 Irish and French professionals and government officials.

Azelies allows medical facilities to access advanced medical equipment while remaining cost-efficient. Novaerus offers a full-service solution to healthier indoor air using advanced air purification technology. This partnership will allow facilities all over the world to access the latest in healthy air solutions.

Irish-Based Novaerus and Vinamedical Perform Signing Ceremony in Hanoi, Vietnam

Presidents of Ireland and Vietnam witness signing ceremony at Presidential Palace, Hanoi.

Dublin, Ireland – November 7, 2016 – Today, Novaerus and their local strategic partner Vinamedical recognized the introduction of Irish-based Novaerus technology in Vietnam with a signing ceremony at the Presidential Palace in Hanoi. The signing ceremony was witnessed by President of Ireland, Michael D. Higgins and President of Vietnam, Tran Dai Quang, during President Higgins’ State Visit to Vietnam. The Minister for Foreign Affairs and Trade, Charles Flanagan TD, was also in attendance at the ceremonial exchange which was organised by the Embassy of Ireland in Hanoi and Enterprise Ireland.

This event reflects the ongoing commitment both leaders have made to global market expansion and economic growth. The availability of the Novaerus technology in the Vietnamese market is an example of this type of growth.

In partnership with Vinamedical, a leading company in medical equipment supply in the Vietnam market, Novaerus’ airborne pathogen control technology will now be available throughout Vietnam. Anh Tuan Trinh, C.E.O of Vinamedical remarks, “We really appreciate participating in this event”. He continues, “This marks not only another significant step in our global economic development but also our ongoing commitment to provide cutting-edge medical technology in Vietnam and especially our focus in enhancing infection control for the benefit of the citizens.”

Novaerus provides a comprehensive infection defence system for indoor facilities. Strong enough to destroy bacteria, viruses, mould, spores and allergens. Its safe design runs 24/7 to annihilate airborne pathogens. Novaerus technology can be found in healthcare, education, hospitality and other commercial institutions across the globe.

“As a growing, innovative Irish-based company, we produce cutting-edge technology in the area of airborne infection control,” says Kieran McBrien, SVP of Sales, Europe and Asia. “This technology is making a significant difference in the global healthcare market. I am honoured and inspired by the level of recognition and commitment that we’ve seen here today from both President Quang and President Higgins.” He adds, “I am also grateful to Enterprise Ireland, the Irish government overseas commercial support network. Their unstinting and creative support around the world has helped Novaerus enter 35 markets in the last 2 years.”

The signing ceremony will be followed by further economic development discussions. For more details about the visit click here

Susque-View Honored with “Innovation of the Year” Award with Implementation of Novaerus Technology

PA Coalition of Affiliated Healthcare & Living Communities grants 2016 “Innovation of the Year” award and also awarded “no deficiencies” by the Department of Health

Raleigh, NC – November 3, 2016 – Last week, Susque-View Home was honoured with a rare award combination in the Long Term Care industry for both excellence and innovation. The Pennsylvania Coalition of Affiliated Healthcare & Living Communities named them their 2016 “Innovation of the Year” facility for their innovative approach to infection control using Novaerus technology.

Also, the Department of Health (DOH) honoured them with an excellence award. The DOH sends experts to look for deficiencies in nursing homes and only a small fraction, less than 10%, are found to have ‘no deficiency’, but Susque-View is a rare exception.   “In an industry where less than 10% of nursing home facilities receive a ‘no deficiencies’ finding from the Department of Health and are often not seen as innovative, we are inspired and honoured by both of this recent recognition,” says Jamie Aurand, Susque-View Home Administrator.

He continues, “The two honours, arriving so close to one another, underline the excellence of our staff, and the commitment to innovation to make Susque-View a better home. Our choice to install Novaerus technology has not only helped stop the spread of infections, such as flu outbreaks but also cut costs associated with the spread of airborne pathogens.”   The innovation award recognizes a member facility or business for innovative work done to improve the quality of resident care that can be used as an example for others interested in replicating the improvements.   “A resident was recently admitted to the facility who had a very stubborn C-Diff infection,” Aurand said. “Traditional approaches to treatment were unsuccessful,” he said, “but the staff installed a portable Novaerus machine in the patient’s room and within three months, the resident was infection free.”

Novaerus recognizes the hard work and achievement of Susque-View and is proud to provide comprehensive infection defence technologies for its indoor facilities. Its safe design runs 24/7 to annihilate airborne pathogens. Novaerus technology can be found in healthcare, education, hospitality and other commercial institutions across the globe. 

Independent Lab Finds Novaerus Plasma Kills 99.9% Flu Virus on Contact

Novaerus Plasma-Based NV900 Eradicates Airborne Virus

Raleigh, N.C. – October 11, 2016  Aerosol Research and Engineering Lab conducted an independent study with the Novaerus NV900 and found it effective in killing the airborne MS2 virus, a surrogate for influenza. “In a matter of hours, the air showed a 4.4 log reduction, which translates to a 99.99% reduction of the virus in the air,” says Felipe Soberon, Chief Technology Officer of Novaerus.

He continues, “This finding is significant in support of plasma-based air purification technology as a safe and effective approach to infection control measures.” Facilities from healthcare to hotels and schools are plagued during the flu season. Flu viruses, however, are usually transmitted through droplets coughed or sneezed into the air. Alone, traditional hand washing and cleaning methods are not enough to prevent and contain outbreaks. During the flu season, it is critical to destroy viruses in the air before they are inhaled or land on surfaces. This provides a comprehensive infection defence system for high traffic indoor facilities. Strong enough to destroy bacteria, viruses, mould, spores and allergens. Its safe design runs 24/7 to annihilate airborne pathogens. Novaerus is committed to the highest indoor air quality.

Developed in 2008, Novaerus technology generates what is called a Dielectric Barrier Discharge plasma or DBD. When microorganisms in the air, including toxins, come into contact with the DBD plasma, they are eliminated. Novaerus enables facilities to reduce negative financial impacts associated with viral outbreaks, such as staff absenteeism. To learn more about Novaerus and its air quality control solutions, visit www.novaerus.com.

Novaerus Encourages Healthcare Professionals to Pledge Commitment to Clean Air

New pledge lays out Novaerus’ fight against invisible threats with innovative technology

Raleigh, N.C. – August 8, 2016 – Novaerus today introduces a call to healthcare, education and hospitality professionals to pledge their commitment to clean air through total annihilation of invisible threats.   “The introduction of plasma-based solutions for airborne pathogen control is a 21st-century approach to a major public and personal health issue,” said Terry Sullivan, MD of NTST consulting. “The spread of infectious diseases, especially those with high levels of antibiotic resistance, is a serious threat to patients within healthcare facilities.”   The pledge, centred on total annihilation of invisible threats, seeks to defend what matters most – the air we breathe, the people we love and those who care for our loved ones.

Novaerus will be among exhibitors at the Florida Health Care Association annual trade show and conference on August 8 in Orlando, Fla. to launch the campaign and educate the industry on the importance of clean air. Novaerus, a company that produces infection prevention technology, uses state of the art plasma coils to safely remove 99.9% of harmful pathogens in the air.

Developed in 2008, Novaerus technology generates what is called a Dielectric Barrier Discharge (DBD) plasma. When microorganisms in the air, including toxins, come into contact with the DBD plasma, they are eliminated. The technology is a green solution that saves 30% on energy costs each year.  The technology Novaerus uses is a completely different approach to air quality control, and it works. The company has proven technology in high-population spaces where germs commonly pose serious risks, such as hospitals, long-term health care facilities and hotels. In the 30 countries where Novaerus products are used, studies to date show that Novaerus technology effectively reduces the bio-burden in the air.   To learn more about Novaerus and its air quality control solutions, visit www.novaerus.com.